Clinical Trials · NCT01455883
A Study to Evaluate ITCA 650 Compared to Glimepiride for the Treatment of Type 2 Diabetes
- Phase
- Phase 3
- Recruitment status
- Withdrawn
- Sponsor
- Intarcia Therapeutics
- Enrollment
- 0
- Start date
- Feb 2013
- Locations
- 1 site, United States
- Primary endpoint
- Change in HbA1c